These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 2025432)

  • 21. Evaluation of Motexafin gadolinium (MGd) as a contrast agent for intraoperative MRI.
    Hirschberg H; Wu GN; Madsen SJ
    Minim Invasive Neurosurg; 2007 Dec; 50(6):318-23. PubMed ID: 18210352
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparison of magnetic resonance imaging sequences in dogs with multi-focal intracranial disease.
    Cherubini GB; Platt SR; Howson S; Baines E; Brodbelt DC; Dennis R
    J Small Anim Pract; 2008 Dec; 49(12):634-40. PubMed ID: 18684139
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Gadolinium-enhanced three-dimensional magnetization-prepared rapid gradient-echo (3D MP-RAGE) imaging is superior to spin-echo imaging in delineating brain metastases.
    Takeda T; Takeda A; Nagaoka T; Kunieda E; Takemasa K; Watanabe M; Hatou T; Oguro S; Katayama M
    Acta Radiol; 2008 Dec; 49(10):1167-73. PubMed ID: 18979271
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Use of contrast media in neuroimaging.
    Essig M; Dinkel J; Gutierrez JE
    Magn Reson Imaging Clin N Am; 2012 Nov; 20(4):633-48. PubMed ID: 23088943
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Perfusion by magnetic resonance imaging: its physical foundations and clinical application].
    Fayed-Miguel N; Castillo-Blandino J; Medrano-Lin J
    Rev Neurol; 2010 Jan 1-15; 50(1):23-32. PubMed ID: 20073020
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Gadolinium-based magnetic resonance contrast agents for neuroradiology: an overview.
    Kanal E
    Magn Reson Imaging Clin N Am; 2012 Nov; 20(4):625-31. PubMed ID: 23088942
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Contrast-enhanced MR imaging in neuroimaging.
    Kim BS; Gutierrez JE
    Magn Reson Imaging Clin N Am; 2012 Nov; 20(4):649-85. PubMed ID: 23088944
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Liposomal contrast agents in brain tumor imaging.
    Ghaghada KB; Colen RR; Hawley CR; Patel N; Mukundan S
    Neuroimaging Clin N Am; 2010 Aug; 20(3):367-78. PubMed ID: 20708552
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Principles of contrast enhancement in the evaluation of brain diseases: an overview.
    Runge VM; Muroff LR; Wells JW
    J Magn Reson Imaging; 1997; 7(1):5-13. PubMed ID: 9039588
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Ultrahigh-field magnetic resonance imaging: the clinical potential for anatomy, pathogenesis, diagnosis, and treatment planning in brain disease.
    van der Kolk AG; Hendrikse J; Luijten PR
    Neuroimaging Clin N Am; 2012 May; 22(2):343-62, xii. PubMed ID: 22548936
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effects of contrast dose, delayed imaging, and magnetization transfer saturation on gadolinium-enhanced MR imaging of brain lesions.
    Mathews VP; Caldemeyer KS; Ulmer JL; Nguyen H; Yuh WT
    J Magn Reson Imaging; 1997; 7(1):14-22. PubMed ID: 9039589
    [TBL] [Abstract][Full Text] [Related]  

  • 32. MRI of brain disease in veterinary patients part 1: Basic principles and congenital brain disorders.
    Hecht S; Adams WH
    Vet Clin North Am Small Anim Pract; 2010 Jan; 40(1):21-38. PubMed ID: 19942055
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The importance of precontrast magnetization transfer images.
    Meyer JR; Rabin B; Parrish TB; Russell EJ
    AJR Am J Roentgenol; 1998 Aug; 171(2):520-1. PubMed ID: 9694488
    [No Abstract]   [Full Text] [Related]  

  • 34. Cerebral tumor or pseudotumor?
    Leclercq D; Trunet S; Bertrand A; Galanaud D; Lehéricy S; Dormont D; Drier A
    Diagn Interv Imaging; 2014 Oct; 95(10):906-16. PubMed ID: 25260711
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Advanced techniques using contrast media in neuroimaging.
    Ferré JC; Shiroishi MS; Law M
    Magn Reson Imaging Clin N Am; 2012 Nov; 20(4):699-713. PubMed ID: 23088946
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [High field MRI for diagnosis of brain tumors].
    Nakada T
    Nihon Rinsho; 2005 Sep; 63 Suppl 9():216-21. PubMed ID: 16201526
    [No Abstract]   [Full Text] [Related]  

  • 37. Central nervous system: review of clinical use of contrast media.
    Runge VM; Muroff LR; Jinkins JR
    Top Magn Reson Imaging; 2001 Aug; 12(4):231-63. PubMed ID: 11687713
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Contrast agents in functional MR imaging.
    Sorensen AG; Tievsky AL; Ostergaard L; Weisskoff RM; Rosen BR
    J Magn Reson Imaging; 1997; 7(1):47-55. PubMed ID: 9039593
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Cardiovascular magnetic resonance in the diagnosis of myocarditis].
    Petryka J; Miśko J; Małek LA; Spiewak M; Miłosz B; Bilińska Z; Ruzyłło W
    Kardiol Pol; 2010 Jul; 68(7):824-9. PubMed ID: 20648447
    [No Abstract]   [Full Text] [Related]  

  • 40. [MRI for diagnosis of brain tumors].
    Kizu O; Nishimura T
    Nihon Rinsho; 2005 Sep; 63 Suppl 9():212-5. PubMed ID: 16201525
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.